Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Albany International
AIN
$1.74B
| $1.6M | ﹤0.01% |
17,159
+839
| +5% | +$75.4K |
|
1977
Origin Bancorp
OBK
$1.67B
| $1.6M | ﹤0.01% |
54,622
+4,049
| +8% | +$121K |
|
1978
Corcept Therapeutics
CORT
$11.7B
| $1.6M | ﹤0.01% |
71,687
-14,274
| -17% | -$329K |
|
1979
HSBC
HSBC
$352B
| $1.59M | ﹤0.01% |
40,207
-150
| -0.4% | -$5.6K |
|
|
CVSA
1980
Covista Inc
CVSA
$4.23B
| $1.59M | ﹤0.01% |
46,166
+15,024
| +48% | +$601K |
|
1981
Comstock Resources
CRK
$3.88B
| $1.58M | ﹤0.01% |
136,232
+52,138
| +62% | +$543K |
|
1982
Independent Bank Corp
IBCP
$793M
| $1.58M | ﹤0.01% |
93,007
+2,747
| +3% | +$47.1K |
|
|
HEES
1983
DELISTED
H&E Equipment Services
HEES
| $1.58M | ﹤0.01% |
34,466
+6,136
| +22% | +$245K |
|
1984
Carvana
CVNA
$75.1B
| $1.57M | ﹤0.01% |
302,835
+36,640
| +14% | +$102K |
|
1985
PJT Partners
PJT
$4.42B
| $1.57M | ﹤0.01% |
22,480
+10,280
| +84% | +$710K |
|
1986
Banc of California
BANC
$3.01B
| $1.57M | ﹤0.01% |
135,190
+73,130
| +118% | +$844K |
|
1987
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.16B
| $1.56M | ﹤0.01% |
20,034
-96,918
| -83% | -$7.93M |
|
1988
Anavex Life Sciences
AVXL
$304M
| $1.56M | ﹤0.01% |
192,151
+2,538
| +1% | +$21.7K |
|
1989
La-Z-Boy
LZB
$1.63B
| $1.56M | ﹤0.01% |
54,537
+14,191
| +35% | +$396K |
|
1990
Sigma Lithium
SGML
$1.21B
| $1.56M | ﹤0.01% |
38,746
+1,760
| +5% | +$67.1K |
|
1991
Quaker Houghton
KWR
$2.88B
| $1.56M | ﹤0.01% |
8,004
+81
| +1% | +$15.8K |
|
1992
Genworth Financial
GNW
$3.72B
| $1.56M | ﹤0.01% |
311,606
+22,411
| +8% | +$123K |
|
1993
Dana Inc
DAN
$2.94B
| $1.56M | ﹤0.01% |
91,604
-28,952
| -24% | -$422K |
|
1994
FTAI Aviation
FTAI
$22.7B
| $1.56M | ﹤0.01% |
49,185
-108,653
| -69% | -$3.08M |
|
1995
Invesco Solar ETF
TAN
$1.45B
| $1.55M | ﹤0.01% |
21,734
+15,854
| +270% | +$1.14M |
|
1996
Forward Air
FWRD
$563M
| $1.55M | ﹤0.01% |
14,581
+943
| +7% | +$96.5K |
|
1997
Capitol Federal Financial
CFFN
$1.11B
| $1.55M | ﹤0.01% |
250,740
+108,589
| +76% | +$675K |
|
1998
FS KKR Capital
FSK
$3.33B
| $1.55M | ﹤0.01% |
80,615
+80,600
| +537,333% | +$1.52M |
|
1999
Keros Therapeutics
KROS
$211M
| $1.54M | ﹤0.01% |
38,393
+9,047
| +31% | +$397K |
|
|
HSAI
2000
Hesai Group
HSAI
$2.79B
| $1.54M | ﹤0.01% |
146,140
+139,040
| +1,958% | +$1.38M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.